Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.63 |
| ▸ | CNR1 | P21554 | 1/20 | 0.63 |
| ▸ | CNR2 | P34972 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.44 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.44 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9447587 | 1.00 | FAAH (0.63) | FAAHCNR1CNR2LMNAMAPT | |
| SCHEMBL4600576 | 1.00 | FAAH (0.63) | FAAHCNR1CNR2LMNAMAPT | |
| SCHEMBL29829684 | 1.00 | FAAH (0.63) | FAAHCNR1CNR2LMNAMAPT | |
| SCHEMBL11787690 | 0.98 | FAAH (0.61) | FAAHCNR1CNR2LMNAMAPT | |
| SCHEMBL8362073 | 0.98 | FAAH (0.60) | FAAHCNR1CNR2LMNAMAPT | |
| SCHEMBL9986402 | 0.94 | FAAH (0.65) | FAAHCNR1CNR2LMNAMAPT | |
| SCHEMBL27918401 | 0.94 | FAAH (0.65) | FAAHCNR1CNR2LMNAMAPT | |
| SCHEMBL365376 | 0.92 | LMNA (0.69) | FAAHCNR1CNR2LMNAMAPT | |
| SCHEMBL22223951 | 0.92 | LMNA (0.69) | FAAHCNR1CNR2LMNAMAPT | |
| SCHEMBL9768561 | 0.92 | LMNA (0.69) | FAAHCNR1CNR2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0906417-B1 | CROSS-LINKED PROTEIN CRYSTAL FORMULATIONS AND THEIR USE AS CATALYSTS IN ORGANIC SOLVENTS | ALTUS PHARMACEUTICALS INC (US) | 2008-04-23 | — | — | EP | disclosed |
| EP-1283898-B1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED ESTERS AND ALCOHOLS | DSM IP ASSETS BV (NL) | 2006-05-10 | — | — | EP | disclosed |
| US-6841691-B2 | Process for the preparation of enantiomerically enriched esters and alcohols | DSM N.V. (NL) | 2005-01-11 | — | — | US | disclosed |
| US-20040077059-A1 | Process for the preparation of enantiomerically enriched esters and alcohols | DSM IP ASSETS B.V. (NL) | 2004-04-22 | — | — | US | disclosed |
| EP-1283898-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED ESTERS AND ALCOHOLS | DSM N.V. (NL) | 2003-02-19 | — | — | EP | disclosed |
| WO-2001090396-A1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY ENRICHED ESTERS AND ALCOHOLS | DSM N.V. (NL) | 2001-11-29 | — | — | WO | disclosed |
| US-6042824-A | COMBINING THE SUBSTRATE AND A CROSSLINKED ENZYME CRYSTAL FORMULATION CONTAINING A CROSSLINKED ENZYME AND A SURFACTANT WHICH ACTS UPON THE SUBSTRATE IN PRESENCE OF ORGANIC SOLVENT OR AQUEOUS-ORGANIC SOLVENT TO FORM A PRODUCT | ALTUS BIOLOGICS, INC. (US) | 2000-03-28 | — | — | US | disclosed |
| US-5932212-A | BLEND CONTAINING SURFACTANT; BIOCATALYST | ALTUS BIOLOGICS, INC. (US) | 1999-08-03 | — | — | US | disclosed |
| EP-0906417-A1 | CROSS-LINKED PROTEIN CRYSTAL FORMULATIONS AND THEIR USE AS CATALYSTS IN ORGANIC SOLVENTS | Altus Biologics Inc. (US) | 1999-04-07 | — | — | EP | disclosed |
| WO-1997044445-A1 | CROSS-LINKED PROTEIN CRYSTAL FORMULATIONS AND THEIR USE AS CATALYSTS IN ORGANIC SOLVENTS | ALTUS BIOLOGICS INC. (US) | 1997-11-27 | — | — | WO | disclosed |
| US-5395935-A | Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents | PFIZER INC. (US) | 1995-03-07 | — | — | US | disclosed |
| US-5270206-A | Enzymatic resolution of endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents | PFIZER INC. (US) | 1993-12-14 | — | — | US | disclosed |
| US-5256569-A | Reacting alcohols with triglycerides | CHISSO CORPORATION (JP) | 1993-10-26 | — | — | US | disclosed |
| EP-0231089-B1 | PROCESS FOR PRODUCING AN OPTICALLY ACTIVE ALCOHOL BY A BIOCHEMICAL METHOD | Chisso Corporation (JP) | 1992-09-30 | — | — | EP | disclosed |
| WO-1991007501-A1 | ENZYMATIC RESOLUTION OF ENDO-BICYCLO[2.2.1]HEPTAN-2-OL AND DERIVED PHARMACEUTICAL AGENTS | PFIZER INC. (US) | 1991-05-30 | — | — | WO | disclosed |
| EP-0231089-A2 | Process for producing an optically active alcohol by a biochemical method | Chisso Corporation (JP) | 1987-08-05 | — | — | EP | disclosed |